Cord blood banking for potential future transplantation

Mitchell S. Cairo, Joanne Kurtzberg, Bertram H. Lubin, William T. Shearer, Stephen A. Feig, James J. Corrigan, Alan S. Gamis, Eric D. Kodish, Peter A. Lane, John J. Hutter, Roger L. Berkow, Naomi L. Lubin, Edwin N. Forman, Laura Laskosz, Paul V. Williams, Bradley E. Chipps, Mary B. Fasano, Mitchell R. Lester, Scott H. Sicherer, Frank S. VirantSami L. Bahna, Michael J. Welch, Gary S. Rachelefsky, Todd A. Mahr, Pamela T. Kanda

Research output: Contribution to journalReview articlepeer-review

120 Scopus citations

Abstract

In recent years, umbilical cord blood, which contains a rich source of hematopoietic stem and progenitor cells, has been used successfully as an alternative allogeneic donor source to treat a variety of pediatric genetic, hematologic, immunologic, and oncologic disorders. Because there is diminished risk of graft-versus-host disease after transplantation of cord stem cells using matched related donors, the use of less-than-completely matched HLA cord blood stem cells may incur less risk of graft-versus-host disease than mismatched cells from either a related or unrelated "walking" donor, although this remains to be proven. Gene-therapy research involving modification of autologous cord blood stem cells for the treatment of childhood genetic disorders, although experimental at the present time, may prove to be of value. These scientific advances have resulted in the establishment of not-for-profit and for-profit cord blood-banking programs for allogeneic and autologous cord blood transplantation. Many issues confront institutions that wish to establish or participate in such programs. Parents often seek information from their physicians about this new biotechnology option. This document is intended to provide information to guide physicians in responding to parents' questions about cord blood donation and banking and the types and quality of cord blood banks. Provided also are recommendations about appropriate ethical and operational standards, including informed consent policies, financial disclosures, and conflict-of-interest policies for physicians, institutions, and organizations that operate or have a relationship with cord blood-banking programs.

Original languageEnglish
Pages (from-to)165-170
Number of pages6
JournalPediatrics
Volume119
Issue number1
DOIs
StatePublished - Jan 2007

Keywords

  • Cord blood
  • Hematology
  • Oncology
  • Stem cells

Fingerprint

Dive into the research topics of 'Cord blood banking for potential future transplantation'. Together they form a unique fingerprint.

Cite this